Latest News on: home

Canada OKs Osiris drug; first stem cell therapy

Fri, 18 May 2012 01:57:00 +0000

BOSTON (Reuters) - Osiris Therapeutics Inc said on Thursday that Canadian health regulators have approved its treatment for acute graft-versus host disease in children, making it the first stem cell drug to be approved for a systemic disease anywhere in the world. Osiris shares rose 14 percent to $6.00 in extended trading after the news was announced. Graft versus host disease (GvHD) is a potentially deadly complication from a bone marrow transplant, when newly implanted cells attack the patient's body. ...

Source: news.yahoo.com Via Infonary: home News

Zebrafish study helps shed light on autism, schizophrenia and obesity

Fri, 18 May 2012 00:43:00 +0000

Human gene isolation in zebrafish may help shed light on autism, says a new study.

Source: www.globalpost.com Via Infonary: home News

GSK melanoma drug shows promise in early trial

Fri, 18 May 2012 00:38:00 +0000

LONDON (Reuters) - An experimental cancer drug developed by Britain's GlaxoSmithKline may add vital months to the lives of melanoma patients whose disease has spread to their brains, according to data from an early-stage trial published on Friday. Results of Phase I trial published in The Lancet medical journal showed substantial shrinking of tumors in patients treated with the drug, dabrafenib, and showed promise against secondary melanoma tumors, or metastases, in the brain. ...

Source: news.yahoo.com Via Infonary: home News

Sex, age may affect athletes' concussion recovery

Fri, 18 May 2012 00:35:00 +0000

(Reuters) - Female and high school athletes may need more time to recover from a concussion than their male or college counterparts, according to a U.S. study that comes amid rising concern about concussions in young athletes.

Source: news.yahoo.com Via Infonary: home News

Fewer Young Americans Smoking, Survey Finds

Fri, 18 May 2012 00:33:00 +0000